Evidence of wide variation in the use of proton pump inhibitors (PPIs) as prophylaxis in haematology patients raises concerns about unnecessary costs and the risk of adverse events. A retrospective review of prescribing practices at the Austin Hospital over 14 months found about 60% of myeloma, lymphoma and autograft patients received PPI prophylaxis during and ...
Inappropriate PPI use widespread in haematology patients
By Mardi Chapman
14 Feb 2019